Filter by category

Published: July 16, 2024

Advancing personalized tissue therapies: VERIGRAFT P-TEV clinical trial update

We are excited to share progress from our ongoing Phase I/II clinical trial in Europe, where eleven of the planned fifteen patients have now been treated with our Personalized Tissue-Engineered Vein (P-TEV) product. Four of these eleven patients have completed the twelve-month follow-up period. The trial is evaluating P-TEV’s potential…